info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +1-315-636-4233    uk UK: +44-162-237-0614     in IN: +91-826-083-6500
Home » Healthcare » Diagnostic Electrocardiograph Market Growth, Forecast 2030

Diagnostic Electrocardiograph (ECG) Market By Product Type (Product (Resting ECG Devices, Stress ECG Devices, Holter Monitors, Implantable Loop Recorders, Event Monitors, MCT Devices, Smart ECG Monitors), Software and Service), By Lead Type (12-lead, 5-lead, 3-lead, 6-lead, Single-lead, Other Lead Types), By End-User (Hospitals & Clinics, Home, Ambulatory Care), By Geography, Size, Share, Trends, Global Industry Report, Forecast, 2021-2030

Published On: Jun-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2017 - 2020   |   Formats: PDF   |   Report ID: 54614119

Industry Report and Statistics (Facts & Figures) - Sales Volume & ASP by Product Type & End-users

The global diagnostic electrocardiograph market will witness a robust CAGR of 5.58%, valued at $5.39 billion in 2021, expected to appreciate and reach $8.79 billion by 2030, confirms Strategic Market Research. North America currently has the largest industry size, with a revenue share valued at 38.76%. A diagnostic electrocardiograph (ECG) is a device used to diagnose common heart problems non-invasive and painlessly. Electrocardiography is the most commonly performed diagnostic procedure. According to the American Heart Association, more than 100 million electrocardiographic procedures are performed every year in the United States of America, with 21% of electrocardiographs done in annual health examinations, while 17% are done during emergency department visits.

Diagnostic electrocardiograms are helpful in the prevention of myocardial infarction (heart attack) by analyzing heart parameters in the initial stages. Electrocardiographs can efficiently detect the patient’s cardiac condition after surgery or after the application of anesthesia. An ECG test is quick, painless, safe, and inexpensive.

 

diagnostic ecg market by share 2020-2030

 

Key Industry Drivers - Increasing Frequency of Heart Diseases, High Accuracy of ECG

  • The key reason driving the global diagnostic electrocardiograph market is the prevalence of cardiac illnesses. The WHO stated that cardiovascular disease is one of the main causes of mortality globally. Around 18 million people die of cardiovascular illnesses annually, accounting for 31% of global fatalities. The high frequency of cardiovascular diseases drives the demand for diagnostic electrocardiographs and increases industry growth.

 

  • Electrocardiographs are more accurate than other forms of cardiac diagnosis, which increases the demand for diagnostic electrocardiographs and helps in the industry's growth. According to the American Heart Association, diagnostic electrocardiographs are 88% accurate in measuring cardiac rhythm. Sinus rhythm was correctly interpreted 95% of the time.

 

Restraints - High Costs of Diagnostic Electrocardiographs

  • Because of the cost-effectiveness aspect, clinicians in many third-world nations are forced to employ older ECG machines rather than the most advanced devices. As a result of high purchasing and maintenance costs and a lack of technical skills, an expansion of the diagnostic ECG market is hindered in emerging nations.

 

Opportunities - New Technological Advancements

  • Technological advances and increased access to innovative treatment procedures will drive the electrocardiograph (ECG) industry. Exercise Testing system and cardio data management can quickly treat rising arrhythmia, coronary artery disease, and cardiomyopathy cases using Resting ECG, Ambulatory ECG, pacemaker, Holter monitor, and Event monitor. According to an NCBI study, more than 2.6 per 1000 people in the United States of America have pacemakers attached to treat different heart conditions. The widespread use of pacemakers rose with age, with 0.4 per 1000 people using pacemakers in the age group 18-64, while 26 per 1000 people used pacemakers in the age group 65+. The new technological advancements and access to innovative treatment procedures can boost the mobile ECG devices, home ECG, and ECG equipment industry.

 

Market Analysis Of Different Segments Covered in the Report

Based on Product Type

  • Product

    • Resting ECG Devices

    • Stress ECG Devices

    • Holter Monitors

    • Implantable Loop Recorders

    • Event Monitors

    • MCT Devices

    • Smart ECG Monitors

  • Software and Service

 

Based on Lead Type

  • 12-lead

  • 5-lead

  • 3-lead

  • 6-lead

  • Single-lead

  • Other Lead Types

 

Based on End-User

  • Hospitals & Clinics

  • Home

  • Ambulatory Care

 

Regional Coverage Analysis

North America

  • United States of America

  • Canada

 

Europe

  • United Kingdom

  • France

  • Spain

  • Italy

  • Russia

  • Germany

  • Rest of Europe

 

The Asia-Pacific

  • China

  • India

  • South Korea

  • Japan

  • Australia

  • Rest of Asia Pacific

 

LAMEA

  • Mexico

  • Brazil

  • South Africa

  • Argentina

  • Saudi Arabia

  • Rest of LAMEA

 

diagnostic ecg market by product 2020-2030

 

Segments Analysis & Insights

The Resting ECG Devices segment accounts for 64% of the entire diagnostic ECG market, making it the highest market with a robust share. It will be the fastest-growing segment, growing at a CAGR of 5.4%. This is mostly due to faster, more accurate diagnosis with no preparatory time. According to the Victorian Department of Health, a resting ECG usually takes 5 to 10 minutes to diagnose a patient when his body is perfectly at rest. Furthermore, it rapidly detects specific heart problems such as hypertrophy of the heart, ischemia, myocardial infarction, sequelae of myocardial infarction, and cardiac arrhythmias, which contribute to the expansion of this segment. According to the CDC, around 800,000 people yearly suffer from myocardial infarction. About 600,000 experienced myocardial infarction for the first time, while the rest have previously experienced the disease.

Holter monitors are expected to have the fastest growth in the industry. Holter ECG monitors are regarded as the most prominent kind of ambulatory ECG monitoring, which led to their extensive use in detecting many cardiovascular diseases. Holter monitors are found to be less expensive than traditional ECG machines. According to a study, the cost of a Holter monitor was around USD 64, while a traditional ECG costs USD 128. The evolution of wireless Holter monitors widely contributed to their rapid growth in the global diagnostic ECG industry.

 

3-6 Lead had the greatest market share in the diagnostic electrocardiograph market. This is primarily because it is frequently employed in numerous cardiac diagnostic examinations. Furthermore, its high accuracy rate at a low cost contributes to the expansion of this segment. According to an NCBI study, a 3-lead ECG is 96.6% more accurate than a 12-lead ECG, and according to another study, 3-lead ECG costs about USD 34 while a 12-lead ECG costs about USD 90.

Hospitals and Clinics represented the highest market share, with 47.22% in 2019, due to the increasing number of individuals seeking cardiovascular disease diagnosis and treatment in hospitals. According to the CDC, 4.6% of US adults have been diagnosed with coronary heart disease. 6.9% of Americans visited physician offices due to their cardiovascular diseases. 7.2% of Americans have visited emergency departments to diagnose and treat these diseases. Furthermore, increased expenditure on purchasing ECG gadgets for better cardiac treatment increases the segment’s growth.

 

North America dominated the diagnostic ECG market, accounting for 38.76% of the total market share due to the region’s growing frequency of cardiovascular disorders. According to AHA (American Heart Association), approximately 82.6 million Americans currently have one or more forms of cardiovascular disease, and according to CDC, about 659,000 Americans die of these diseases each year.

However, the Asia-Pacific region is poised to increase at the fastest CAGR of 6.8%. This is due to an expanding general population and an increase in chronic illnesses. According to an NCBI study, more than 290 million people suffer from cardiovascular diseases in China. Approximately 13 million Chinese suffered from a stroke, while around 11 million had coronary heart disease.

 

Diagnostic Electrocardiograph Market Report Coverage

Report Attribute

Details

Forecast Period

2021 – 2030

The market size value in 2021

USD 5.39 billion

The revenue forecast in 2030

USD 8.79 billion

Growth rate

CAGR of approximately 5.58%

The base year for estimation

2021

Historical data

2017 – 2020

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

By Product Type, By Lead Type, By End-User, and By Region.

By Product Type

Stress ECG Devices, Holter Monitors, and Resting ECG Devices

By Lead Type

Single Lead, 3-6 Lead, 12-Lead

By End-User

Hospitals & Clinics, Home, Ambulatory Care

By Region

Asia-Pacific, North America, Europe, LAMEA

Country Scope

United States of America, United Kingdom, France, Germany, Italy, Spain, Russia, Canada, China, India, Japan, South Korea, Australia, Brazil, Mexico, Argentina, Saudi Arabia, South Africa, etc.

Company Usability Profiles

Nihon Kohden Corporation, GE Healthcare, Koninklijke Philips NV, Medtronic, Hill-Rom Holdings (a subsidiary of Baxter International), SCHILLER, BPL Medical Technologies, ACS Diagnostics, BTL, Ambu A/S, Allengers Medical Systems, Ltd., FUKUDA DENSHI, Innomed Medical, Edan Instruments,Inc., Cardioline SpA, Eccosur, Suzuken Co.Ltd, Norav Medical, VectraCor, Inc., Bionet Co., Ltd., Nexus Lifecare, Midmark Corporation, OSI Systems, Inc and SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS Co., Ltd

 

Diagnostic Electrocardiograph Market Competitive Landscape Analysis

The market is extremely fragmented, with numerous important competitors. Companies focus on large partnerships, mergers, and acquisitions to increase their market share. Market participants are also working on research and development to increase product quality, reduce manufacturing costs, and design better devices to promote patient compliance and safety.

 

 

diagnostic ecg market by region 2020-2030

 

Recent Developments

  • In March 2022, GE Healthcare announced its partnership with AliveCor. Medical professionals can access GE Healthcare’s MUSE system using the KardiaMobile 6L ECG device. The partnership aims to increase patient convenience and reduce cardio-based hospitalizations by improving the patient’s data quality and integration.

 

  • In January 2022, Koninklijke Philips introduced a first-at-home, 12-lead ECG integrated solution for decentralized clinical trials. Koninklijke Philips aims to improve patient retention, compliance, and trial by introducing a new system to reduce the need and burden for clinical trials.

 

  • In December 2021, Baxter International, Inc. announced the acquisition of Hillrom for USD 12.5 billion. The Hillrom acquisition ushers in the next chapter of Baxter’s transformation, bringing a new wave of promise to deliver greater impact for patients, clinicians, workers, shareholders, and other communities the firm serves worldwide.

 

  • In July 2021, Medtronic announced FDA clearance for two of its AccuRhythm™ AI Algorithms with the LINQ II™ insertable cardiac monitor. Applying AccuRhythm AI to LINQ II data is a key ICM breakthrough, allowing Medtronic to decrease clinical inefficiencies caused by false alarms and assist physicians in better identifying and focusing on the relevant data they require to treat their patients.

 

  • In February 2021, Koninklijke Philips NV announced its acquisition of Biotelemetry, Inc. The acquisition of BioTelemetry fits well with Philips’ cardiac care portfolio and its strategy to enhance care delivery throughout the health continuum with integrated solutions.

 

List of Diagnostic Electrocardiographs that Key Market Leaders Develop:

Product

Function

Key Player

ECG-3150

Identification of arrhythmia

Nihon Kohden

Electrocardiograph CardiMax FX-8400

Identification of the presence of acute myocardial infarction.

Fukuda Denshi

GE ECG Machine Mac 2000

Fast and Accurate Diagnosis of Cardiac issues.

GE Healthcare

Philips ECG Machine PageWriter TC50

A better interpretation of rhythm and morphology for pediatric and adult patients.

Koninklijke Philips NV

Suzuken Cardy 302 MAX Waterproof Holter ECG recorder

Wearable Holter recorder.

Suzuken Co. Ltd.

 

Frequently Asked Question About This Report

The Resting ECG segment accounts for 64% of the diagnostic ECG market share by product type.

Asia-Pacific region is the fastest-growing diagnostic ECG market geographically, with a CAGR of 6.8%.

The global diagnostic electrocardiograph market is expected to grow at a compound annual growth rate (CAGR) of 5.58% from 2021 to 2030 to reach USD 8.79 billion by 2030.

The global diagnostic electrocardiograph (ECG) market size was $5.39 billion in 2021 and is expected to reach $8.79 billion in 2030, propelling at a CAGR of 5.58%.

The market growth rate of the diagnostic ECG market is 5.58%.

The main drivers for the growth of the diagnostic ECG market are the increasing frequency of heart diseases and the rising demand for minimally invasive techniques and lifestyle changes.

Sources

https://www.heart.org/en/health-topics/heart-attack/diagnosing-a-heart-attack/electrocardiogram-ecg-or-ekg

https://www.ncbi.nlm.nih.gov/books/NBK507823/

https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/ecg-test

https://www.cdc.gov/heartdisease/facts.htm

https://www.johnahartford.org/blog/view/giving-thanks-for-partners-a-new-nursing-postdoctoral-fellowship-with-the-a/

 

 

 

1.   Introduction

       1.1. Study Objective

       1.2. Market Definition        

       1.3. Study Scope

              1.3.1. Markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1. Data Procurement

       2.2. Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

   2.2.2.1 Primary sources

                     2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3. Market Size Estimation

       2.4. Bottom-Up and Top-Down Approaches

              2.4.1.     Bottom-Up Approach

                     2.4.1.1.         Approach for arriving at Market size by bottom-up analysis

              2.4.2.     Top-Down Approach

                     2.4.2.1.         Approach for Capturing Market Size by Top-Down Analysis

       2.5. Market Breakdown and Data Triangulation

       2.6. Research Methodology

       2.7. Risk Assessment

3.  Executive Summary

       3.1 Diagnostic Electrocardiograph Market: Post-Covid-19

              3.1.1      Actual Scenario

              3.1.2      Pessimistic Scenario

              3.1.3      Optimistic Scenario

              3.1.4      Market Summary

4. Industry Outlook

       4.1 Market Snapshot

       4.2 Diagnostic Electrocardiograph Market

              4.2.1       Market, 2021 – 2030 (USD Million)

       4.3 Regional Business Analysis

              4.3.1       Market, by region, 2021-2030 (USD Million)

       4.4 By Product Type Business Analysis

              4.4.1       Market, By Product Type, 2021-2030 (USD Million)

       4.5 By End-User Business Analysis

              4.5.1       Market, By End-User, 2021-2030 (USD Million)

       4.6 Lead Type Business Analysis

              4.6.1       Market, By Lead Type, 2021-2030 (USD Million)

       4.7 Value Chain Analysis

       4.8 Market Variable Analysis

              4.8.1      Market Drivers Analysis

              4.8.2      Market Restraints Analysis

       4.9Business Environment Analysis Tool

              4.9.1      Market PEST analysis

              4.9.2      Market Porter’s analysis

       4.10Penetration & Growth Prospect Mapping

5. Market Dynamics

       5.1. Introduction

       5.2. Market Dynamics

              5.2.1.     Drivers

              5.2.2.     Restraints

              5.2.3.     Opportunities

              5.2.4.     Challenges

       5.3. Impact of Covid-19 On Market

       5.4. Value Chain Analysis

       5.5. Ecosystem

       5.6. Patent Analysis

       5.7. Trade Analysis

       5.8. Tariff Analysis

       5.9. Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1    Threat of New Entrants

              5.10.2    Threat of Substitutes

              5.10.3    Bargaining Power of Buyers

              5.10.4    Bargaining Power of Suppliers

              5.10.5    Degree of Competition

       5.11.              Lead Type Analysis

              5.11.1.   Trends in Lead Type (2014-2020)

              5.11.2.   Trends in Lead Type (2021-2028)

       5.12.              Pricing Analysis

              5.12.1.   Average Price Trend Analysis (By Region, By Countries)

6. Competitive & Vendor Landscape

       6.1. Company Market Share Analysis

       6.2. Manufacturers Manufacturing Sites, Area Served, Product Type

       6.3. Market Competitive Situation and Trends

       6.4. Manufacturers Mergers & Acquisitions, Expansion Plans

7. Market: By Product Type Segment Analysis

       7.1. Introduction

       7.2. Sales Volume & Revenue Analysis (2021-2030)

       7.3. Product

              7.3.1. Product, 2021-2030 (USD Million)

                    7.3.1. Resting ECG Devices, 2021-2030 (USD Million)

                    7.3.1. Stress ECG Devices, 2021-2030 (USD Million)

                    7.3.1. Holter Monitors, 2021-2030 (USD Million)

                    7.3.1. Implantable Loop Recorders, 2021-2030 (USD Million)

                    7.3.1. Event Monitors, 2021-2030 (USD Million)

                    7.3.1. MCT Devices, 2021-2030 (USD Million)

                    7.3.1. Smart ECG Monitors, 2021-2030 (USD Million)

 7.4. Software and Service

              7.4.1. Software and Service Market, 2021-2030 (USD Million)

8.   Market: By End-User Segment Analysis

       8.1. Introduction

       8.2. Sales Volume & Revenue Analysis (2021-2030)

       8.3. Hospitals & Clinics

              8.3.1.     Hospitals & Clinics Market, 2021-2030 (USD Million)

       8.4. Home

              8.4.1.     Home Market, 2021-2030 (USD Million)

       8.5. Ambulatory Care

              8.5.1.     Ambulatory Care Market, 2021-2030 (USD Million)

9.   Market: By Lead Type Segment Analysis

       9.1. Introduction

       9.2. Sales Volume & Revenue Analysis (2021-2030)

       9.3. 12-lead

              9.3.1.     12-lead Market, 2021-2030 (USD Million)

       9.4. 5-lead

              9.4.1.     5-lead Market, 2021-2030 (USD Million)

       9.5. 3-lead

              9.5.1.     3-lead Market, 2021-2030 (USD Million)

       9.5. 6-lead

              9.5.1.     6-lead Market, 2021-2030 (USD Million)

       9.5. Single-lead

              9.5.1.     Single-lead Market, 2021-2030 (USD Million)

       9.5. Other Lead Types

              9.5.1.     Other Lead Types Market, 2021-2030 (USD Million)

10.   Market: Regional Outlook

10.1 North America

              10.1.1.   North America Market, By Product Type, 2021-2030 (USD Million)

              10.1.2.   North America Market, By End-User, 2021-2030 (USD Million)

              10.1.3.   North America Market, by Lead Type, 2021-2030 (USD Million)

              10.1.4.   North America Market, by Country, 2021-2030 (USD Million)

       10.1.4.1. U.S.

                     10.1.4.1.1.   U.S.  Market, By Product Type, 2021-2030 (USD Million)

                     10.1.4.1.2.   U.S.  Market, By End-User, 2021-2030 (USD Million)

                     10.1.4.1.3.   U.S.  Market, by Lead Type, 2021-2030 (USD Million)

10.1.4.2. Canada

                     10.1.4.2.1.   Canada Market, By Product Type, 2021-2030 (USD Million)

                     10.1.4.2.2.   Canada Market, By End-User, 2021-2030 (USD Million)

                     10.1.4.2.3.   Canada Market, by Lead Type, 2021-2030 (USD Million)

10.2. Europe

              10.2.1.   Europe Market, By Product Type, 2021-2030 (USD Million)

              10.2.2.   Europe Market, By End-User, 2021-2030 (USD Million)

              10.2.3.   Europe Market, by Lead Type, 2021-2030 (USD Million)

              10.2.4.   Europe Market, by country, 2021-2030 (USD Million)

10.2.4.1    U.K.

                     10.2.4.1.1.   U.K.  Market, By Product Type, 2021-2030 (USD Million)

                     10.2.4.1.2.   U.K.  Market, By End-User, 2021-2030 (USD Million)

                     10.2.4.1.3.   U.K.  Market, by Lead Type, 2021-2030 (USD Million)

10.2.4.2.              Germany

                     10.2.4.2.1.   Germany Market, By Product Type, 2021-2030 (USD Million)

                     10.2.4.2.2.   Germany Market, By End-User, 2021-2030 (USD Million)

                     10.2.4.2.3.   Germany Market, by Lead Type, 2021-2030 (USD Million)

10.2.4.3.              France

                     10.2.4.3.1.   France Market, By Product Type, 2021-2030 (USD Million)

                     10.2.4.3.2.   France Market, By End-User, 2021-2030 (USD Million)

                     10.2.4.3.3.   France Market, by Lead Type, 2021-2030 (USD Million)

10.2.4.4.              Rest of Europe

                     10.2.4.4.1.   Rest of Europe Market, By Product Type, 2021-2030 (USD Million)

                     10.2.4.4.2.   Rest of Europe Market, By End-User, 2021-2030 (USD Million)

                     10.2.4.4.3.   Rest of Europe Market, by Lead Type, 2021-2030 (USD Million)

       10.3.              Asia Pacific

              10.3.1.   Asia Pacific Market, By Product Type, 2021-2030 (USD Million)

              10.3.2.   Asia Pacific Market, By End-User, 2021-2030 (USD Million)

              10.3.3.   Asia Pacific Market, by Lead Type, 2021-2030 (USD Million)

              10.3.4.   Asia Pacific Market, by country, 2021-2030 (USD Million)

10.3.4.1.              China

                     10.3.4.1.1.   China Market, By Product Type, 2021-2030 (USD Million)

                     10.3.4.1.2.   China Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.1.3.   China Market, by Lead Type, 2021-2030 (USD Million)

10.3.4.2.              India

                     10.3.4.2.1.   India Market, By Product Type, 2021-2030 (USD Million)

                     10.3.4.2.2.   India Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.2.3.   India Market, by Lead Type, 2021-2030 (USD Million)

10.3.4.3.              Japan

                     10.3.4.3.1.   Japan Market, By Product Type, 2021-2030 (USD Million)

                     10.3.4.3.2.   Japan Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.3.3.   Japan Market, by Lead Type, 2021-2030 (USD Million)

10.3.4.4.              South Korea

                     10.3.4.4.1.   South Korea Market, By Product Type, 2021-2030 (USD Million)

                     10.3.4.4.2.   South Korea Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.4.3.   South Korea Market, by Lead Type, 2021-2030 (USD Million)

10.3.4.5.              Rest of ASIA PACIFIC

                     10.3.4.5.1.   Rest of ASIA PACIFIC Market, By Product Type, 2021-2030 (USD Million)

                     10.3.4.5.2.   Rest of ASIA PACIFIC Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.5.3.   Rest of ASIA PACIFIC Market, by Lead Type, 2021-2030 (USD Million)

       10.4.              Latin America

              10.4.1.   Latin America Market, By Product Type, 2021-2030 (USD Million)

              10.4.2.   Latin America Market, By End-User, 2021-2030 (USD Million)

              10.4.3.   Latin America Market, by Lead Type, 2021-2030 (USD Million)

              10.4.4.   Latin America Market, by country, 2021-2030 (USD Million)

10.4.4.1.              Brazil

                     10.4.4.1.1.   Brazil Market, By Product Type, 2021-2030 (USD Million)

                     10.4.4.1.2.   Brazil Market, By End-User, 2021-2030 (USD Million)

                     10.4.4.1.3.   Brazil Market, by Lead Type, 2021-2030 (USD Million)

10.4.4.2.              Mexico

                     10.4.4.2.1.   Mexico Market, By Product Type, 2021-2030 (USD Million)

                     10.4.4.2.2.   Mexico Market, By End-User, 2021-2030 (USD Million)

                     10.4.4.2.3.   Mexico Market, by Lead Type, 2021-2030 (USD Million)

                     10.4.4.3.       Rest of Latin America

                     10.4.4.3.1.   Rest of the Latin America Market, By Product Type, 2021-2030 (USD Million)

                     10.4.4.3.2.   Rest of the Latin America Market, By End-User, 2021-2030 (USD Million)

                     10.4.4.3.3.   Rest of the Latin America Market, by Lead Type, 2021-2030 (USD Million)

       10.5.              MEA

              10.5.1.   MEA Market, By Product Type, 2021-2030 (USD Million)

              10.5.2.   MEA Market, By End-User, 2021-2030 (USD Million)

              10.5.3.   MEA Market, by Lead Type, 2021-2030 (USD Million)

              10.5.4.   MEA Market, by Region, 2021-2030 (USD Million)

 

11. Competitive Landscape

11.1 GE Healthcare

              11.1.1.   Company overview

              11.1.2.   Financial performance

              11.1.3.   Product Portfolio Analysis

              11.1.4.   Business Strategy & Recent Development

11.2. Nihon Kohden Corporation

              11.2.1.   Company overview

              11.2.2.   Financial performance

              11.2.3.   Product Portfolio Analysis

              11.2.4.   Business Strategy & Recent Development

11.3. Koninklijke Philips NV

              11.3.1.   Company overview

              11.3.2.   Financial performance

              11.3.3.   Product Portfolio Analysis

              11.3.4.   Business Strategy & Recent Development

11.4. HEYER MEDICAL AG

              11.4.1.   Company overview

              11.4.2.   Financial performance

              11.4.3.   Product Portfolio Analysis

              11.4.4.   Business Strategy & Recent Development

11.5. Hill-Rom Holdings

              11.5.1.   Company overview

              11.5.2.   Financial performance

              11.5.3.   Product Portfolio Analysis

              11.5.4.   Business Strategy & Recent Development

11.6. SCHILLER

              11.6.1.   Company overview

              11.6.2.   Financial performance

              11.6.3.   Product Portfolio Analysis

              11.6.4.   Business Strategy & Recent Development

11.7. BPL Medical Technologies

              11.7.1.   Company overview

              11.7.2.   Financial performance

              11.7.3.   Product Portfolio Analysis

              11.7.4.   Business Strategy & Recent Development

11.8. ACS Diagnostics

              11.8.1.   Company overview

              11.8.2.   Financial performance

              11.8.3.   Product Portfolio Analysis

              11.8.4.   Business Strategy & Recent Development

11.9. BTL

              11.9.1.   Company overview

              11.9.2.   Financial performance

              11.9.3.   Product Portfolio Analysis

              11.9.4.   Business Strategy & Recent Development

11.10. Allengers Medical Systems, Ltd

              11.10.1. Company overview

              11.10.2. Financial performance

              11.10.3. Product Portfolio Analysis

              11.10.4. Business Strategy & Recent Development

11.11. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS Co., Ltd

              11.11.1. Company overview

              11.11.2. Financial performance

              11.11.3. Product Portfolio Analysis

              11.11.4. Business Strategy & Recent Development

11.12. FUKUDA DENSHI

              11.12.1. Company overview

              11.12.2. Financial performance

              11.12.3. Product Portfolio Analysis

              11.12.4. Business Strategy & Recent Development

11.13. Innomed Medical

              11.13.1. Company overview

              11.13.2. Financial performance

              11.13.3. Product Portfolio Analysis

              11.13.4. Business Strategy & Recent Development

11.14. Edan Instruments, Inc

              11.14.1. Company overview

              11.14.2. Financial performance

              11.14.3. Product Portfolio Analysis

              11.14.4. Business Strategy & Recent Development

11.15. Cardioline SpA

              11.15.1. Company overview

              11.15.2. Financial performance

              11.15.3. Product Portfolio Analysis

              11.15.4. Business Strategy & Recent Development

 11.16. Eccosur

              11.16.1. Company overview

              11.16.2. Financial performance

              11.16.3. Product Portfolio Analysis

              11.16.4. Business Strategy & Recent Development

11.17. Suzuken Co. Ltd

              11.17.1. Company overview

              11.17.2. Financial performance

              11.17.3. Product Portfolio Analysis

              11.17.4. Business Strategy & Recent Development

11.18. Norav Medical

              11.18.1. Company overview

              11.18.2. Financial performance

              11.18.3. Product Portfolio Analysis

              11.18.4. Business Strategy & Recent Development

11.19. VectraCor, Inc

              11.19.1. Company overview

              11.19.2. Financial performance

              11.19.3. Product Portfolio Analysis

              11.19.4. Business Strategy & Recent Development

11.20. Bionet Co., Ltd

              11.20.1. Company overview

              11.20.2. Financial performance

              11.20.3. Product Portfolio Analysis

              11.20.4. Business Strategy & Recent Development

11.21. Nexus Lifecare

              11.21.1. Company overview

              11.21.2. Financial performance

              11.21.3. Product Portfolio Analysis

              11.21.4. Business Strategy & Recent Development

11.22. Midmark Corporation

              11.22.1. Company overview

              11.22.2. Financial performance

              11.22.3. Product Portfolio Analysis

              11.22.4. Business Strategy & Recent Development

11.23. OSI Systems, Inc

              11.23.1. Company overview

              11.23.2. Financial performance

              11.23.3. Product Portfolio Analysis

              11.23.4. Business Strategy & Recent Development

 

List of Tables (86 Tables)

TABLE 1.   Market, By Product Type, 2021-2030 (USD Million)

TABLE 2.   Market FOR Product, BY REGION, 2021-2030 (USD Million)

TABLE 3.   Market FOR Resting ECG Devices, BY REGION, 2021-2030 (USD Million)

TABLE 4.   Market FOR Stress ECG Devices, BY REGION, 2021-2030 (USD Million)

TABLE 5.   Market FOR Holter Monitors, BY REGION, 2021-2030 (USD Million)

TABLE 6.   Market FOR Implantable Loop Recorders, BY REGION, 2021-2030 (USD Million)

TABLE 7.   Market FOR Event Monitors, BY REGION, 2021-2030 (USD Million)

TABLE 8.   Market FOR MCT Devices, BY REGION, 2021-2030 (USD Million)

TABLE 9.   Market FOR Smart ECG Monitors, BY REGION, 2021-2030 (USD Million)

TABLE 10.   Market FOR Software and Service, BY REGION, 2021-2030 (USD Million)

TABLE 11.  Market, By End-User, 2021-2030 (USD Million)

TABLE 12.  Market FOR Hospitals & Clinics, BY REGION, 2021-2030 (USD Million)

TABLE 13.  Market FOR Home, BY REGION, 2021-2030 (USD Million)

TABLE 14.  Market FOR Ambulatory Care, BY REGION, 2021-2030 (USD Million)

TABLE 15.  Market, BY LEAD TYPE, 2021-2030 (USD Million)

TABLE 16.  Market FOR 12-lead, BY REGION, 2021-2030 (USD Million)

TABLE 17.  Market FOR 5-lead, BY REGION, 2021-2030 (USD Million)

TABLE 18.  Market FOR 3-lead, BY REGION, 2021-2030 (USD Million)

TABLE 19.  Market FOR 6-lead, BY REGION, 2021-2030 (USD Million)

TABLE 20.  Market FOR Single-lead, BY REGION, 2021-2030 (USD Million)

TABLE 21.  Market FOR Other Lead Types, BY REGION, 2021-2030 (USD Million)

TABLE 22.  Market, BY REGION, 2021-2030 (USD Million)

TABLE 23. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 24. NORTH AMERICA Market, By Product Type, 2021-2030 (USD Million)

TABLE 25. NORTH AMERICA Market, By End-User, 2021-2030 (USD Million)

TABLE 26. NORTH AMERICA Market, BY LEAD TYPE, 2021-2030 (USD Million)

TABLE 27. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 28. EUROPE Market, By Product Type, 2021-2030 (USD Million)

TABLE 29. EUROPE Market, By End-User, 2021-2030 (USD Million)

TABLE 30. EUROPE Market, BY LEAD TYPE, 2021-2030 (USD Million)

TABLE 31. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 32. ASIA-PACIFIC Market, By Product Type, 2021-2030 (USD Million)

TABLE 33. ASIA-PACIFIC Market, By End-User, 2021-2030 (USD Million)

TABLE 34. ASIA-PACIFIC Market, BY LEAD TYPE, 2021-2030 (USD Million)

TABLE 35. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 36. LAMEA Market, By Product Type, 2021-2030 (USD Million)

TABLE 37. LAMEA Market, By End-User, 2021-2030 (USD Million)

TABLE 38. LAMEA Market, BY LEAD TYPE, 2021-2030 (USD Million)

TABLE 39. GE Healthcare: COMPANY SNAPSHOT

TABLE 40. GE Healthcare: OPERATING SEGMENTS

TABLE 41. Nihon Kohden Corporation: COMPANY SNAPSHOT

TABLE 42. Nihon Kohden Corporation: OPERATING SEGMENTS

TABLE 43. Koninklijke Philips NV: COMPANY SNAPSHOT

TABLE 44. Koninklijke Philips NV: OPERATING SEGMENTS

TABLE 45. Medtronic: COMPANY SNAPSHOT

TABLE 46. Medtronic: OPERATING SEGMENTS

TABLE 47. Hill-Rom Holdings: COMPANY SNAPSHOT

TABLE 48. Hill-Rom Holdings: OPERATING SEGMENTS

TABLE 49. SCHILLER: COMPANY SNAPSHOT

TABLE 50. SCHILLER: OPERATING SEGMENTS

TABLE 51. BPL Medical Technologies: COMPANY SNAPSHOT

TABLE 52. BPL Medical Technologies: OPERATING SEGMENTS

TABLE 53. ACS Diagnostics: COMPANY SNAPSHOT

TABLE 54. ACS Diagnostics: OPERATING SEGMENTS

TABLE 55. BTL: COMPANY SNAPSHOT

TABLE 56. BTL: OPERATING SEGMENTS

TABLE 57. Ambu A/S: COMPANY SNAPSHOT

TABLE 58. Ambu A/S: OPERATING SEGMENTS

TABLE 59. Allengers Medical Systems, Ltd: COMPANY SNAPSHOT

TABLE 60. Allengers Medical Systems, Ltd: OPERATING SEGMENTS

TABLE 61. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS Co., Ltd: COMPANY SNAPSHOT

TABLE 62. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS Co., Ltd: OPERATING SEGMENTS

TABLE 63. FUKUDA DENSHI: COMPANY SNAPSHOT

TABLE 64. FUKUDA DENSHI: OPERATING SEGMENTS

TABLE 65. Innomed Medical: COMPANY SNAPSHOT

TABLE 66. Innomed Medical: OPERATING SEGMENTS

TABLE 67. Edan Instruments, Inc: COMPANY SNAPSHOT

TABLE 68. Edan Instruments, Inc: OPERATING SEGMENTS                

 TABLE 69. Cardioline SpA: COMPANY SNAPSHOT

TABLE 70. Cardioline SpA: OPERATING SEGMENTS                

TABLE 71. Eccosur: COMPANY SNAPSHOT

TABLE 72. Eccosur: OPERATING SEGMENTS                

TABLE 73. Suzuken Co. Ltd: COMPANY SNAPSHOT

TABLE 74. Suzuken Co. Ltd: OPERATING SEGMENTS                

TABLE 75. Norav Medical: COMPANY SNAPSHOT

TABLE 76. Norav Medical: OPERATING SEGMENTS                

TABLE 77. VectraCor, Inc: COMPANY SNAPSHOT

TABLE 78. VectraCor, Inc: OPERATING SEGMENTS                

TABLE 79. Bionet Co., Ltd: COMPANY SNAPSHOT

TABLE 80. Bionet Co., Ltd: OPERATING SEGMENTS                

TABLE 81. Nexus Lifecare: COMPANY SNAPSHOT

TABLE 82. Nexus Lifecare: OPERATING SEGMENTS                

TABLE 83. Midmark Corporation: COMPANY SNAPSHOT

TABLE 84. Midmark Corporation: OPERATING SEGMENTS                

TABLE 85. OSI Systems, Inc: COMPANY SNAPSHOT

TABLE 86. OSI Systems, Inc: OPERATING SEGMENTS                

 

List of Figures (22 Figures)

Figure 1 Diagnostic Electrocardiograph Market: Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries:  Market

Figure 4 Research Methodology: Hypothesis Building

Figure 5 Market: Product-Based Estimation

Figure 6 Top 24 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2020

Figure 8 Import Data for Diagnostic Electrocardiograph, By Country, 2016–2020 (USD Thousand)

Figure 9 Export Data for Diagnostic Electrocardiograph, By Country, 2016–2020 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11 Market, By End-User, 2019 vs 2025 (USD Million)

Figure 12 Market Share, By Lead Type, 2019 vs 2025 (USD Million)

Figure 13 Market Share, By Product Type, 2019 vs 2025 (USD Million)

Figure 14 Geographical Snapshot of the Market

Figure 15 Resting ECG Devices to Witness Higher CAGR in Market for Product Type Segment during Forecast Period.

Figure 16 3-lead, 6-lead to Witness Higher CAGR in Market for Lead Type Segment during Forecast Period.

Figure 17 Hospitals & Clinics to Witness Higher CAGR in the Market for End-User Segment during Forecast Period.

Figure 18 North America Region Accounted for the Largest Share of the Market, By Regional Basis, in 2019

Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges

Figure 20 North America:  Market Snapshot

Figure 21 Asia Pacific:  Market Snapshot

Figure 22 Vendor Dive: Evaluation Overview